AgenusvsMerck & Company

AGEN and MRK stock compared: price, dividend, valuation and results, from SEC filings.

AGEN

Agenus Inc.

$6.14

Value $385M

+3.06%
AGEN's page

MRK

Merck & Company, Inc.

$132.81

Value $328B

-3.90%
MRK's page

Agenus (AGEN) has a market value of $385M and Merck & Company (MRK) $328B. Over the last year, with dividends, AGEN moved +48.1% and MRK +52.7%. The P/E is 13.1 for AGEN and 133.9 for MRK. Dividend yield: AGEN none, MRK 2.56%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AGEN$385M

    MRK$328B

    MRK is 854 times AGEN

  • Revenue, 12 months

    AGEN$134M

    MRK$67.4B

    MRK is 503 times AGEN

  • Net income, 12 months

    AGEN$29M

    MRK$2.5B

    MRK is 83 times AGEN

  • Operating margin

    AGEN38.9%

    MRK–

  • ROIC

    AGEN–

    MRK3.9%

  • P/E

    AGEN13.1

    MRK133.9

    MRK is 10 times AGEN

  • Dividend yield

    AGEN0.0%

    MRK2.6%

    2.6 points apart

  • 5-year return

    AGEN-90.6%

    MRK+94.3%

    184.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AGEN-90.6%

MRK+94.3%

010020020222023202420252026
Returns by period
PeriodAGENWith dividendsMRKWith dividends
1 year since November 17, 2025+48.1%Price +48.1%+52.7%Price +48.4%
3 years since November 17, 2023-53.6%-22.6% a yearPrice -53.6%+48.4%+14.1% a yearPrice +35.4%
5 years since November 17, 2021-90.6%-37.7% a yearPrice -90.6%+94.3%+14.2% a yearPrice +66.8%
10 years since November 21, 2016-93.2%-23.6% a yearPrice -93.2%+214.5%+12.1% a yearPrice +131.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AGENAgenusMRKMerck & Company

Valuation

AGENMRK
Valuation
Price$6.14$132.81
Market value$385M$328B
Enterprise value (EV)–$372B
P/E13.1133.9
P/E, 5-year median–14.8
P/B–7.3
EV/EBIT–78.2
Free cash flow yield–4.5%

Results and growth

AGENMRK
Results and growth
Revenue, 12 months$134M$67.4B
Net income, 12 months$29M$2.5B
Free cash flow, 12 months-$104M$14.7B
Earnings per share, 12 months$0.47$0.98
Revenue growth, year on year10.4%1.3%
Revenue growth a year, past+5.3%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

AGENMRK
Margins and returns on capital
Gross margin100.0%71.8%
Operating margin38.9%–
Net margin22.0%3.6%
ROIC–3.9%
ROE–5.2%

Balance sheet

AGENMRK
Balance sheet
Cash$87M$9.7B
Total debt–$53.8B
Net debt / EBITDA–5.7
Interest cover0.9×2.4×

Dividends and buybacks

AGENMRK
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.6%
Shareholder yield–4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AGEN or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Agenus or Merck & Company?

By market value, Merck & Company ($328B) is about 853.6 times Agenus ($385M), at today's prices.

How did AGEN and MRK stock do over the last 10 years?

Since November 21, 2016, AGEN's price moved -93.2% and MRK's +131.8%. With dividends: AGEN -93.2% (-23.6% a year), MRK +214.5% (+12.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, AGEN or MRK?

The dividend yield at today's price is none for Agenus and 2.56% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of AGEN and MRK?

At today's price, the P/E is 13.1 for AGEN and 133.9 for MRK. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Agenus or Merck & Company?

Over the last twelve months, the net margin was 22.0% for Agenus and 3.6% for Merck & Company, and the operating margin 38.9% and –. Revenue was $134M and $67.4B.

Which is the better investment, Agenus or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.